Baijin Life Science Holdings Limited (01466.HK)

Baijin Life Science Holdings Ltd. is an investment company, which engages in the design, process, purchase, production, and distribution of pearl and jewellery products. The company employs 79 full-time employees The company went IPO on 2014-10-17. The firm operates the business through five segments. The Sales of Pearls and Jewellery Products segment is engaged in the design and sale of jewellery products as well as sale of pearls. The Brand marketing and Consulting Services segment is engaged in the provision of brand marketing and consulting services based on contracts with agreed terms of services. The Skincare Solutions Business segment is engaged in the sales of skincare solution products to cosmetic stores and hospitals by sales contracts as well as individuals via online sales platforms, under the brand name FO. The Research and Development Services segment is engaged in the Provision of professional scientific services. The Strategic Investment and Financial Services segment is engaged in the real estate financial assets investment.